Esperion Therapeutics
ESPR
#6819
Rank
S$0.59 B
Marketcap
$3.03
Share price
8.06%
Change (1 day)
144.35%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -S$54.54 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.27 Billion. In 2023 the company made an earning of -S$0.2 Billion, an increase over its 2022 earnings that were of -S$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$54.54 Million-72.66%
2023 -S$0.2 Billion-15.03%
2022 -S$0.24 Billion-20.61%
2021 -S$0.3 Billion84.28%
2020 -S$0.17 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.27 Billion19.57%
2017 -S$0.23 Billion125.39%
2016 -S$99.02 Million51.43%
2015 -S$65.39 Million36.45%
2014 -S$47.92 Million43.55%
2013 -S$33.39 Million145.26%
2012 -S$13.62 Million
2002 -S$38.81 Million-7.81%
2001 -S$42.1 Million15.03%
2000 -S$36.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.7 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.51 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.61 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.59 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.14 Billion 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.27 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA